The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Owen Mumford sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Owen Mumford Ltd (Owen Mumford) is a medical device company that designs, manufactures and markets diagnostic equipment and disposables. The company offers injection pens and needles, blood sampling lancets, eye care solutions, neuropathy screening devices, and vaginal dilators. These products find application in the diagnosis, monitoring, treatment and management of conditions such as allergy reaction testing, cancer, cholesterol, diabetes, migraine, Parkinson’s, multiple sclerosis, point of care and rheumatoid arthritis, among others. Owen Mumford serves hospitals, healthcare professionals and patients across the world. The company markets its products through direct sales offices, and a network of distributors in over 60 countries. Owen Mumford is headquartered in Oxfordshire, the UK. Key subsidiaries of Owen Mumford include Owen Mumford, Empelvic and Owen Mumford.
The key metrics of Owen Mumford related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Owen Mumford is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Owen Mumford.
For a detailed understanding of the performance of Owen Mumford, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
